1. Home
  2. SCLX vs ARAY Comparison

SCLX vs ARAY Comparison

Compare SCLX & ARAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scilex Holding Company

SCLX

Scilex Holding Company

N/A

Current Price

$4.90

Market Cap

35.2M

Sector

Health Care

ML Signal

N/A

Logo Accuray Incorporated

ARAY

Accuray Incorporated

N/A

Current Price

$0.23

Market Cap

31.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SCLX
ARAY
Founded
2011
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
35.2M
31.3M
IPO Year
2020
2006

Fundamental Metrics

Financial Performance
Metric
SCLX
ARAY
Price
$4.90
$0.23
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$3.50
AVG Volume (30 Days)
36.4K
455.4K
Earning Date
04-10-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
87.50
EPS
N/A
N/A
Revenue
$30,253,000.00
N/A
Revenue This Year
$122.52
N/A
Revenue Next Year
$186.30
$4.58
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.20
$0.22
52 Week High
$34.27
$2.10

Technical Indicators

Market Signals
Indicator
SCLX
ARAY
Relative Strength Index (RSI) 27.24 36.12
Support Level $4.20 $0.23
Resistance Level $7.77 $0.29
Average True Range (ATR) 0.30 0.02
MACD 0.01 -0.00
Stochastic Oscillator 5.93 0.73

Price Performance

Historical Comparison
SCLX
ARAY

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.

About ARAY Accuray Incorporated

Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention. The company has one operating segment which develops, manufactures and markets proprietary medical devices used in radiation therapy for the treatment of cancer patients.

Share on Social Networks: